中国成为跨国企业研发热土

Core Viewpoint - A significant increase in foreign investment in research and development (R&D) in China reflects multinational companies' commitment to enhancing local innovation capabilities, aligning with China's economic transformation from a manufacturing base to a research hub [1][4]. Group 1: Foreign Investment Trends - From January to August 2025, 42,435 new foreign-invested enterprises were established in China, marking a 14.8% year-on-year increase, indicating sustained enthusiasm for foreign investment and an optimized investment structure [2]. - Over the past decade, R&D expenditure of foreign-funded industrial enterprises in China has increased by over 86.5% [2]. - Shanghai has surpassed 600 foreign R&D centers, while Beijing's number has doubled compared to the previous year [2]. Group 2: Sector-Specific Developments - In the pharmaceutical sector, AstraZeneca announced a $2.5 billion investment to establish a global strategic R&D center in Beijing, making it one of two such centers in China [3]. - Schneider Electric has established multiple R&D centers in China, with an annual compound growth rate of over 18% in R&D investment since 2019, and has built five major R&D centers and AI innovation labs [3]. Group 3: Innovation Ecosystem - China's market size, policy environment, and innovation ecosystem are increasingly attractive to foreign enterprises, fostering a conducive environment for R&D [4]. - The Chinese market is characterized by strong growth potential and a welcoming attitude towards innovation, which is crucial for the rapid commercialization of new technologies and products [4]. Group 4: Global Impact of Local Innovations - Bayer's investment in a health consumer innovation center in Shanghai reflects confidence in China's stable policy environment for R&D, enhancing collaboration with local research institutions [5]. - Cross-national companies are leveraging innovations developed in China to serve global markets, with Bayer's innovative products from China accounting for 15% of its global innovation output as of 2023 [7]. Group 5: Technological Advancements - The rapid development of new technologies such as artificial intelligence and green energy presents significant market opportunities for multinational companies, positioning China as a key player in these fields [6]. - AstraZeneca is utilizing AI technology in China to accelerate scientific discoveries, exemplifying the integration of advanced technologies in local R&D efforts [6]. Group 6: Strategic Responses to Market Needs - Companies are increasingly focusing on local market characteristics to enhance competitiveness, with Henkel emphasizing the importance of R&D in China to respond quickly to market demands [7]. - Schneider Electric's innovations, such as environmentally friendly switchgear, developed in China, are being promoted globally, showcasing the international relevance of local R&D efforts [8].